CD274 and metabolic syndrome: In the cases of benign tumors included in the study, the absence of immunoreaction for PD-L1 was statistically significantly associated with the presence of dyslipidemia (p = 0.006), diabetes (p = 0.024), and hypertension (p = 0.040).